Skip to main content

Pharmacy

By Jeff Lagasse | 04:11 pm | January 26, 2022
AGS believes it's premature for CMS to issue a coverage determination for other antibodies in the pipeline that don't yet have FDA approval.
By Susan Morse | 05:52 pm | January 23, 2022
Most people with a health plan can go online or to a pharmacy to purchase an at-home COVID-19 test at no cost.
By Jeff Lagasse | 01:08 pm | January 19, 2022
The policy is set to begin in March, at which point new access restrictions will be placed on all drugs other than the company's IMiD offerings.
By Jeff Lagasse | 04:19 pm | January 18, 2022
Patients had a high level of trust in pharmacists to complete most activities, including prescribing medications and providing counseling.
By Susan Morse | 12:01 pm | January 18, 2022
This applies in the 24 states where the vaccine mandate was reinstated by last week's Supreme Court's decision.
By Susan Morse | 12:33 pm | January 14, 2022
The Justices upheld mandates for healthcare workers but say OSHA standards overstepped federal power.
By Susan Morse | 08:02 pm | January 12, 2022
Arguments center on Aduhelm's price, its questionable clinical benefit and why the agency is going against FDA approval of the drug.
By Susan Morse | 06:00 pm | January 11, 2022
Currently, Aduhelm, made by Biogen, is the only monoclonal antibody approved by the FDA for the treatment of Alzheimer's disease.
By Susan Morse | 05:10 pm | January 10, 2022
Premiums covered the $56,000 yearly cost of the Alzheimer's drug Aduhelm, but that price has been slashed by 50%.
By Susan Morse | 12:01 pm | January 04, 2022
The maker of Humira wants 340B hospitals to submit requested claims data to a web-based platform.